Literature DB >> 10592276

KinMutBase, a database of human disease-causing protein kinase mutations.

K A Stenberg1, P T Riikonen, M Vihinen.   

Abstract

KinMutBase (http://www.uta.fi/imt/bioinfo/KinMutBase/) is a registry of mutations in human protein kinases related to disorders. Kinases are essential cellular signaling molecules, in which mutations can lead to diseases, including immunodeficiencies, cancers and endocrine disorders. The first release of KinMutBase contained information for protein tyrosine kinases. The current release includes also serine/threonine protein kinases, as well as an update of the tyrosine kinases. There are 251 entries altogether, representing 337 families and 621 patients. Mutations appear both in conserved hallmark residues of the kinases as well as in non-homologous sites. The KinMutBase WWW pages provide plenty of information, namely mutation statistics and display, clickable sequences with mutations and changes to restriction enzyme patterns.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10592276      PMCID: PMC102425          DOI: 10.1093/nar/28.1.369

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  29 in total

1.  Mutations of the human BTK gene coding for bruton tyrosine kinase in X-linked agammaglobulinemia.

Authors:  M Vihinen; S P Kwan; T Lester; H D Ochs; I Resnick; J Väliaho; M E Conley; C I Smith
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

Review 2.  BTK, the tyrosine kinase affected in X-linked agammaglobulinemia.

Authors:  M Vihinen; P T Mattsson; C I Smith
Journal:  Front Biosci       Date:  1997-01-01

3.  Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism.

Authors:  L B Giebel; R A Spritz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

4.  NIDDM associated with mutation in tyrosine kinase domain of insulin receptor gene.

Authors:  S Cocozza; A Porcellini; G Riccardi; A Monticelli; G Condorelli; A Ferrara; L Pianese; C Miele; B Capaldo; F Beguinot
Journal:  Diabetes       Date:  1992-04       Impact factor: 9.461

5.  Structural basis for chromosome X-linked agammaglobulinemia: a tyrosine kinase disease.

Authors:  M Vihinen; D Vetrie; H S Maniar; H D Ochs; Q Zhu; I Vorechovský; A D Webster; L D Notarangelo; L Nilsson; J M Sowadski
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

6.  ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency.

Authors:  A C Chan; T A Kadlecek; M E Elder; A H Filipovich; W L Kuo; M Iwashima; T G Parslow; A Weiss
Journal:  Science       Date:  1994-06-10       Impact factor: 47.728

7.  Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.

Authors:  T Furitsu; T Tsujimura; T Tono; H Ikeda; H Kitayama; U Koshimizu; H Sugahara; J H Butterfield; L K Ashman; Y Kanayama
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

8.  Crystal structure of the tyrosine kinase domain of the human insulin receptor.

Authors:  S R Hubbard; L Wei; L Ellis; W A Hendrickson
Journal:  Nature       Date:  1994 Dec 22-29       Impact factor: 49.962

9.  Parent-of-origin effects in multiple endocrine neoplasia type 2B.

Authors:  K M Carlson; J Bracamontes; C E Jackson; R Clark; A Lacroix; S A Wells; P J Goodfellow
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

10.  Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3.

Authors:  P L Tavormina; R Shiang; L M Thompson; Y Z Zhu; D J Wilkin; R S Lachman; W R Wilcox; D L Rimoin; D H Cohn; J J Wasmuth
Journal:  Nat Genet       Date:  1995-03       Impact factor: 38.330

View more
  9 in total

1.  Computational modeling of structurally conserved cancer mutations in the RET and MET kinases: the impact on protein structure, dynamics, and stability.

Authors:  Anshuman Dixit; Ali Torkamani; Nicholas J Schork; Gennady Verkhivker
Journal:  Biophys J       Date:  2009-02       Impact factor: 4.033

2.  A rational free energy-based approach to understanding and targeting disease-causing missense mutations.

Authors:  Zhe Zhang; Shawn Witham; Marharita Petukh; Gautier Moroy; Maria Miteva; Yoshihiko Ikeguchi; Emil Alexov
Journal:  J Am Med Inform Assoc       Date:  2013-02-13       Impact factor: 4.497

3.  Human SBK1 is dysregulated in multiple cancers and promotes survival of ovary cancer SK-OV-3 cells.

Authors:  Pingzhang Wang; Jinhai Guo; Feng Wang; Taiping Shi; Dalong Ma
Journal:  Mol Biol Rep       Date:  2010-11-20       Impact factor: 2.316

Review 4.  Exploring Missense Mutations in Tyrosine Kinases Implicated with Neurodegeneration.

Authors:  Neha Sami; Vijay Kumar; Asimul Islam; Sher Ali; Faizan Ahmad; Imtaiyaz Hassan
Journal:  Mol Neurobiol       Date:  2016-08-20       Impact factor: 5.590

5.  The energy landscape analysis of cancer mutations in protein kinases.

Authors:  Anshuman Dixit; Gennady M Verkhivker
Journal:  PLoS One       Date:  2011-10-06       Impact factor: 3.240

6.  Evolution of protein kinase substrate recognition at the active site.

Authors:  David Bradley; Pedro Beltrao
Journal:  PLoS Biol       Date:  2019-06-24       Impact factor: 8.029

7.  KinaseMD: kinase mutations and drug response database.

Authors:  Ruifeng Hu; Haodong Xu; Peilin Jia; Zhongming Zhao
Journal:  Nucleic Acids Res       Date:  2021-01-08       Impact factor: 16.971

8.  Sequence and structure signatures of cancer mutation hotspots in protein kinases.

Authors:  Anshuman Dixit; Lin Yi; Ragul Gowthaman; Ali Torkamani; Nicholas J Schork; Gennady M Verkhivker
Journal:  PLoS One       Date:  2009-10-16       Impact factor: 3.240

9.  HKPocket: human kinase pocket database for drug design.

Authors:  Huiwen Wang; Jiadi Qiu; Haoquan Liu; Ying Xu; Ya Jia; Yunjie Zhao
Journal:  BMC Bioinformatics       Date:  2019-11-29       Impact factor: 3.169

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.